Skip to main content
Download PDF

Body mass index as a dominant risk factor for metabolic syndrome among indonesian adults: a 6-year prospective cohort study of non-communicable diseases

BMC Nutrition volume 10, Article number: 43 (2024) Cite this article

Abstract

Background

Non-communicable diseases (NCDs), notably cardiovascular disease and type 2 diabetes mellitus, are largely driven by metabolic syndrome (MetS), a cluster of critical risk factors. Despite extensive research, the progression of MetS, especially in Indonesia, has received limited attention. This research tracks adult MetS risk dynamics in a populous Bogor District cohort, providing crucial insights into its evolving nature.

Methods

This prospective open cohort study analysed secondary data from the Special Research - Cohort Study of Non-Communicable Diseases by the Ministry of Health, Republic of Indonesia from 2011 to 2018. The final sample was 1,376 Indonesian adult participants, all residents of Bogor District. MetS outcome, dietary assessment, physical activity, and biomarkers were analysed every two consecutive years.

Results

The risk of overweight and obese participants developing MetS was 2.4 and 4.4 times higher, respectively (95% CI: 1.176–3.320 and 3.345–5.740) than those with body mass index (BMI) in the normal range. Participants who reported less intentional physical exercise had a MetS risk 1.5 times higher (95% CI: 1.034–2.109) than those with more intentional physical exercise. The role of diet is also significant, evidenced by a 30% reduction in MetS risk for people with fat intakes in the 2nd quartile compared to the 1st quartile (95% CI: 0.505–0.972). Meanwhile, a carbohydrate intake in the 2nd quartile increased the risk of MetS 1.5 times (95% CI: 1.063–2.241) in comparison with the 1st quartile.

Conclusions

Notably, participants with underweight BMI exhibited the highest cumulative survival of MetS, while those with obese BMI recorded the lowest cumulative survival. There is an urgent need for strategic interventions to enhance the existing early detection and NCD monitoring program. This involves a targeted focus on promoting a community-based healthy lifestyle in the Bogor District. The study emphasizes the importance of tailored public health measures to address specific risk factors identified in the local context, aiming to mitigate the prevalence and impact of MetS in the population.

Peer Review reports

Background

The third of the UN’s Sustainable Development Goals (SDGs) is to “Ensure healthy lives and promote well-being for all at all ages”. Encompassed within this is Target 3.4 which aims to reduce premature mortality from non-communicable diseases (NCDs) by one-third by 2030 through prevention and treatment [1]. Despite the implementation of public health policies around the world to address the issue, the prevalence and burden of NCD including diabetes mellitus, obesity and stroke, continues to rise [2, 3]. Forty-one million deaths per year (equivalent to 71% of all deaths globally) are attributed to NCDs, of which 85% are premature deaths that occur in low- and middle-income countries, including Indonesia [4].

Although NCDs that occur singularly represent a significant public health challenge, they often occur in combination, increasing the burden on healthcare services. Metabolic syndrome (MetS) refers to a group of risk factors that collectively increase the risk of cardiovascular disease, insulin resistance and diabetes mellitus, and vascular and neurological complications such as cerebrovascular diseases [5,6,7]. Metabolic disorders are categorised as MetS if an individual has at least three of the following conditions: (1) abdominal obesity, (2) high triglyceride levels, (3) low levels of high-density lipoprotein cholesterol (HDL), (4) elevated fasting glucose levels, (5) hypertension [8, 9].

Studies suggest that populations with an imbalanced eating pattern [10,11,12], individuals with low levels of physical inactivity [13, 14], certain racial and ethnic groups [9], those with a family history of diabetes (sibling or parent with diabetes), women with a history of polycystic ovarian syndrome, and older adults [15] are more likely to suffer from MetS [9].

In Indonesia, the high prevalence of MetS is also an alarming issue. The prevalence is significantly higher compared to other countries (39%, 29.2%, and 30% in Indonesia, Dutch, and Indian adults, respectively) [6, 16], ranging from 0 to 50% of provincial and ethnic prevalence [5] that may be partially attributed to the susceptibility of Asian populations to metabolic disorders [17]. Without proper management and prevention, MetS can exacerbate the national burden of diseases and healthcare costs, which is particularly relevant to Indonesia following implementation of the National Health Insurance scheme (JKN). JKN aims to provide universal health coverage to the entire population from the shock of sudden health crises, including NCDs, which are the main burden in health financing in the JKN program [18]. In 2021, the amount of JKN claim costs for the NCD was around IDR 18 trillion or USD 1.2 billion (consuming 37% of the total costs) which increased to IDR 24 Trillion or USD 1.5 Billion in 2022. NCDs not only exhaust the resources for provision of healthcare services due to their direct cost but are additionally associated with significant indirect costs to society such as productivity losses [19,20,21,22]. By 2024, the Indonesian government will target all 514 districts/cities to detect NCD risk factors early. In addition, since 2014, the government also has a chronic disease management program (Prolanis) to improve the quality of life of JKN participants and ensure the effectiveness and efficiency of the health care cost.

In order to develop effective prevention programs, several cohort studies have been conducted to better understand the risk factors for MetS and examine MetS components [23,24,25], yet this prior research has limitations including relatively short follow-up times (one to four years) [26], variation in diagnostic criteria for MetS, or studies on populations of different ethnicities, which may affect generalisability to the Indonesian context [27, 28]. Another study also explored MetS incidence using a similar six-year cohort, but did not rigorously select participants based on complete MetS component profiles and medication usage, which could introduce bias [29]. Due to these limitations, there is still a requirement to understand the dynamics of MetS among the Indonesian population and gain a better understanding of the aspects of prevention and promotion. This is highly relevant for Indonesia given that healthcare costs are borne by the government following the implementation of JKN.

To enhance the quality of evidence and provide a more comprehensive understanding of Metabolic Syndrome (MetS) risk factors, this study utilizes data from the Non-Communicable Disease Cohort, conducted between 2011 and 2018 in the Bogor District Residence of West Java, Indonesia. This dataset, characterized by lesser ethnic diversity and the use of uniform diagnostic criteria, along with consistent medical testing methods, offers a unique platform for our investigation. Our research notably extends existing efforts by conducting a longitudinal examination of MetS cumulative survival rates across a broader segment of the adult population over this extended period. This approach not only deepens our understanding of MetS progression in Indonesia but also highlights the influence of diverse lifestyle and environmental factors within this specific demographic context. By focusing on these aspects, our study provides critical insights for the early detection and management of MetS, thus underlining the novelty and significance of our work in the broader landscape of MetS research. This study aims to understand the changes in MetS risk among Indonesian adults with regard to specific risk factors. The results of this study could provide evidence for regional and national health policymakers to design the most appropriate intervention strategy.

Method

Data collection and participants

This study analysed secondary data from the Special Research - Cohort Study of Non-Communicable Diseases (NCD) by the Ministry of Health, Republic of Indonesia. This population-based prospective cohort study began in 2011 and involved around 5,000 participants from 3,441 households reside in five out of eleven villages in Bogor Tengah Sub-district, Bogor City, West Java Provinces, Indonesia. The study employed total population sampling of participants aged 25 years and older who were willing to have routine medical checkups. Additional participants could be recruited at any point during the study (open cohort). Data collectors were local healthcare professionals in collaboration with the Primary Health Care Centre (Puskesmas) and community health cadres, under the supervision of the Health Research Board, Ministry of Health. Participants were monitored three times per year and had a comprehensive medical checkup every two years. This study employed three phases of participant recruitment with initial screenings or examinations conducted in 2011 (phase 1), 2012 (phase 2), and 2015 (phase 3), resulting in the addition of 394 participants to the existing cohort. Despite efforts to maintain participant engagement, we observed a 9% dropout rate over the 6-year observation period, primarily due to death, illness, relocation, and work commitments preventing attendance at scheduled monitoring and examinations [30]. As an open cohort population-based prospective study, it is considered a dynamic cohort that can identify the incidence of diseases [30, 31].

In this study, the initial number of participants was 5,690 adults aged 25 years and above as provided in the dataset. The eligibility criteria were to have complete biomarkers data from baseline (2011) to endline (2018) with no history of MetS or medication regimen related to MetS risk factors (e.g. antihypertensives). We also excluded participants with incomplete independent variables data, including smoking history. The selection process left 1,376 participants to be included in this study (Fig. 1). The meticulous selection was intended to ensure robust findings and distinguish this study form others utilizing the same database.

Fig. 1
figure 1

Flow chart of inclusion and exclusion criteria. a The screening process pertains exclusively to the baseline assessment only

Full size image

Study variables

The observed outcome, MetS, was defined using criteria modified from the National Cholesterol Education Program’s Adult Treatment Panel (NCEP ATP) III criteria, considered for its widely recognized, clinically practical, flexibility and relevance in our study compared to other criteria, namely International Diabetes Foundation (IDF) [32, 33], which states an individual must experience at least three of five conditions as follows: 1) abdominal obesity (waist circumference ≥ 90 cm for men or ≥ 80 cm for women; 2) triglycerides ≥ 150 mg/dL; 3) high-density lipoprotein cholesterol (HDL) < 40 mg/dL for men or < 50 mg/dL for women; 4) fasting blood glucose ≥ 100 mg/dL; and 5) hypertension (systolic blood pressure ≥ 130 mmHg and/or diastolic ≥ 85 mmHg) [33].

Anthropometric measurements, clinical measurements, dietary assessment, sociodemographic profiles, and other risk factors were measured and observed by trained operators and standardised tools. Anthropometric measurements include weight, height, and abdominal circumference. Body mass index (BMI) was calculated from weight and height, then classified based on Asia-Pacific BMI as follows: underweight (< 18.50 kg/m2); normal (18.50–22.99 kg/m2); overweight (23.00–24.99 kg/m2); and obese (≥ 25.0 kg/m2) [34]. Clinical measurements included blood glucose and blood lipid profiles (LDL, HDL, triglyceride, total cholesterol).

Food intake was recorded using a single 24-hour dietary recall. It was conducted for each participant in the early stage of the study and during the monitoring (once every year) or 7 times in total. The dietary information was then assessed for energy, carbohydrate, protein, fat, and sodium composition using Nutrisurvey™. The values of energy, carbohydrate, protein, fat, and sodium intake per day were classified into quartiles, with the lowest quartile (Quartile-1) representing the 25% of participants with the lowest consumption in the study population.

Sociodemographic profiles include education, occupation, and the availability of health insurance. Other identified risk factors include smoking, stress, and physical activity. Physical activity was assessed using standardized questionnaires, that is International Physical Activity Questionnaire (IPAQ) developed by WHO to assess physical activity. It covers several components, such as intensity, duration, and frequency, and it assesses three domains in which physical activity is performed (occupational physical activity, transport-related physical activity, and physical activity during discretionary or leisure time). It was then categorised based on the number of minutes spent on low, moderate, and vigorous-intensity activities daily, self-reported by participants. The number of minutes was converted to metabolic equivalent of task (MET) where: (1) walking MET-minutes/week = 3.3 x walking minutes x walking days, (2) moderate MET-minutes/week = 4.0 x moderate-intensity activity minutes x moderate days, and (3) vigorous MET-minutes/week = 8.0 x vigorous-intensity activity minutes x vigorous-intensity days. The result was subsequently further classified into sufficient physical activity levels (≥ 600 MET-minutes per week) and insufficient physical activity levels (< 600 MET-minutes per week) [35]. A sub-variable for intentional physical exercise was also based on the self-reported number of minutes spent on moderate and vigorous intensity physical exercise and recreational sport. The number of minutes was then classified based on the WHO recommendation for physical activity into sufficient (at least 75 min of vigorous or 150 min of moderate activities per week) and insufficient (less than 75 min of vigorous or 150 min of moderate activities per week) [36]. To adjust for variation in exercise intensity, the reporting of vigorous activity was counted as twice that of the moderate activities, and the cut-off for the grouping was set at 150 min of activities. We did the stratification because the type of the occupation in this population was dominated by manual labour (blue collar worker) which may cause bias in the physical activity estimation, as it does not necessarily mean that they have intentional physical exercise. MetS outcome, dietary assessment, and biomarkers were analysed every two consecutive years based on the availability of the data. Several measurements were recorded, including at baseline in two phases: the year 2011 and 2012, and three follow-up measurements in 2013/2014 (2nd year), 2015/2016 (4th year), and 2017/2018 (6th year) were chosen based on the availability of comprehensive data. Meanwhile, the remaining variables: age, physical activity, smoking status, smoking intensity, stress, education level, occupation, health insurance, family history of diabetes mellitus and heart attack (mortality and morbidity experienced by participants’ parents and grandparents), pregnancy and menopausal status, and delivery of a macrosomic new-born (≥ 4,000gr) were measured once at baseline.

Data analysis

Descriptive statistics were used to examine all variables. Mean and standard deviation (SD) were used to describe numerical values. We employed categorical data analysis, supplemented by non-parametric tests (McNemar, Wilcoxon Mean-Rank, and Friedman) for skewed numerical data. This approach ensures robustness in our bivariate analysis, aligning with the nature of our data and enhancing the validity of our findings. Association between outcome variables and potential risk factors are estimated using Cox Regression with a 5% significance level. We used a person-time of observation to represent the duration between the baseline and MetS occurrence (year-to-MetS). This study’s outcome was to obtain the adjusted Hazard Ratios (HR) and 95% confidence intervals (95% CIs) for all predictors retained in the final model. Statistical analysis of the data was performed using Stata 17 and SPSS Software version 26.

Results

In this study, 1,521 participants were initially observed; 145 were excluded for meeting MetS criteria, leaving 1,376 for a six-year analysis. Within this period, 28.6% developed MetS. Most participants had a normal BMI (39.6%), while 18.7% and 33.3% were overweight and obese. The majority of participants were females (66.3%), under 50 years (78.5%), lacked health insurance (62.72%), worked as government officers (35.25%), completed secondary school (61.92%), current/ex-smokers (50.9%), experienced no stress (58.0%), and showed insufficient intention to exercise (88.5%). Participant characteristics are detailed in Table 1. In our study, the median survival time for obese individuals was observed to be 6 years, with an incidence rate of MetS at 47.72 per 1000 person-years over a 6-year observation period.By the second year, 17.7% of participants developed MetS, increasing to 21.2% in the fourth year and 28.6% by the sixth year (p < 0.001). Notably, waist circumference, triglycerides, and fasting blood glucose levels significantly increased over time (p < 0.001), while low HDL and hypertension showed fluctuations. Obesity prevalence rose from 33.3 to 44.9%, with corresponding decreases in normal and underweight BMI categories. In the second year, obesity was most prevalent (38.2%), with a decline in normal BMI (36.0%). Dietary intakes of energy, protein, fat, and sodium escalated, except for carbohydrates, as detailed in Table 2. However, energy, protein, and sodium intakes in year 2 did not significantly differ from baseline. In our analysis, presented in Fig. 2(a-l), several variables affected the survival rate of Metabolic Syndrome (MetS) by the end of the six-year study. Overweight, obesity, sedentary lifestyles, and high carbohydrate consumption were linked to an increased MetS risk compared to normal BMI, intention to exercise, and low carbohydrate intake. Notably, participants with underweight BMI exhibited the highest cumulative survival rate at 94% in the sixth year. Conversely, those with obese BMI showed the lowest rates, from 66.4% at baseline to 49.3% at endline. Age played a significant role, with younger participants (< 50 years) having lower survival rates than older ones ( > = 50 years). Gender differences were also evident; females had a lower cumulative survival rate (68.3%) compared to males (77.4%).

Table 1 Participants’ characteristics from baseline to endline (N = 1,376)
Full size table
Table 2 Distribution of components of metabolic syndrome and dietary intake based on cohort periods
Full size table
Fig. 2
figure 2

Overall survival rates based on age (a), Sex (b), BMI (c), Smoking Habit (d), Smoking Intensity (e), Stress (f), Physical Exercise (g), Energy Intake (h), Protein Intake (i), Fat Intake (j), Carbohydrate Intake (k), Sodium Intake (l) in years

Full size image

Smoking habits impacted survival, where heavy smokers (> 20 cigarettes per day) had lower survival rates at endline (76.7%) than lighter smokers. Surprisingly, ex-smokers and non-smokers also showed lower survival (70.5% and 67.8%, respectively) compared to those who smoked moderately (77.0%). Participants reporting stress had slightly lower survival rates (70.9%) than non-stressed ones (71.7%). Physical activity levels were critical. Participants with insufficient physical activity had higher cumulative survival at baseline (80.7%) compared to those sufficiently active (70.4%). However, when considering intentional exercise (like sports or recreational activities), those engaging in such exercises had about 8% higher survival than those who did not.

Dietary intake also influenced survival rates. While most nutrients showed fluctuating trends, those in the highest quartile of energy consumption had the lowest survival (69.2%). A similar trend was observed with sodium intake, where higher consumption correlated with lower survival rates, declining from 74.7% in the lowest quartile to 68.0% in the highest.

Multivariate analysis showed that factors influencing MetS survival were BMI, intended exercise and fat and carbohydrate intakes. Participants with underweight BMI had a lower risk of developing MetS (HR = 0.4, 95% CI 0.194–0.919) that indicates a 60% lower risk of developing Metabolic Syndrome (MetS) compared to those with a normal BMI, while overweight and obese participants were 2.4 and 4.4 times more likely to develop MetS (95% CI 1.176–3.320 and 3.345–5.740, respectively) compared to those with normal BMI. In addition, participants who reported less intention to exercise had a MetS risk 1.5 times higher (95% CI 1.034–2.109) than those who were physically active. Dietary fat intakes are also important, evident by an around 30% reduction in MetS risk for fat consumption in the 2nd quartile compared to the 1st quartile On the other hand, carbohydrate intakes in the 2nd quartile increased the risk of MetS 1.5 times (95% CI 1.063–2.241) in comparison to the 1st quartile, and the risk tended to increase in line with higher consumption. Age, sex, smoking habit and intensity, stress, and energy, protein and sodium intake were considered to be confounders (Table 3).

Table 3 The model of the cox regression for the 6-year survival rate of MetS
Full size table

Discussion

This study identified the risk factors for MetS based on six years of follow-up in a cohort of individuals who were not affected by the condition at baseline. By promoting BMI as a key risk factor for metabolic syndrome, policymakers can raise public awareness about the significance of maintaining a healthy weight, adopting healthier lifestyle and promoting physical activity levels. The intervention programs should be tailored to suit the unique needs of the Indonesian population, considering cultural and socioeconomic factors. Collaborative efforts between government agencies, healthcare providers, nutritionists, community organizations, and public health experts can ensure comprehensive and effective interventions that address the underlying causes of high BMI. Empowering primary care physicians with the necessary knowledge and resources to address BMI-related health issues can significantly reduce the burden of metabolic syndrome.

In this population-based cohort study, we investigated the association between risk factors and the survival rate for MetS, defined as the probability of living free from MetS. We demonstrated several principal findings, which are summarised as follows: during the 6-year follow-up period (1) the risk of developing MetS rose with increasing BMI. Obesity reduced the probability of living free from MetS by more than 50% and led to a 4.4-fold increased risk of developing MetS, (2) a sedentary lifestyle significantly increased MetS risk by 1.5 times and reduced the probability of living free from MetS by around 20%, (3) we observed that low and moderate fat intake had a protective effect against MetS and carbohydrate intake was a risk factor for developing MetS. However, this result needs to be carefully interpreted as the lower consumption of fat may be a consequence of having higher consumption of carbohydrate.

Previous studies have consistently reported higher BMI as predictor for MetS [37,38,39]. Other variables that have been reported in addition to BMI include sedentary lifestyle [40, 41], waist-to-hip ratio [42], older age, being female, and lower education level [39]. A population cohort in Korean adults suggested that dietary aspects, such as dietary diversity, was associated with the risk of MetS [43]. Diet and MetS association also supported by a cross-sectional study reported low fruit and vegetable intakes and high alcohol consumption as dietary factors that contribute to MetS risk, alongside high BMI and a sedentary lifestyle [40]. The findings of the present study are, in general, aligned with previous findings and suggested theories. While overweight-obesity and sedentary lifestyle were consistently reported in another population study, this study’s findings in relation to carbohydrate and fat intake as predictors of the future risk of MetS have not been widely reported in other studies. Different dietary patterns and types of carbohydrate and fat consumed in various populations allow diverse outcomes in the risk of MetS [40].

Previous observations related to fat intake and MetS were inconclusive. While some study proposed that high dietary fat intakes are associated with higher risk of MetS [44, 45], some other studies suggested the opposite [46, 47]. Based on a systematic review, the difference was due to the type of fat consumed, as higher polyunsaturated fatty acids (PUFA) was reported to be inversely associated with adiposity and obesity, as well as lower triglyceride levels, increased HDL, and an overall lower risk of MetS [45]. The current analysis shows that low and moderate fat intake lowers the risk of developing MetS. However, this result needs to be carefully interpreted as it could be depending to the type of fat (fatty acids) consumed, which this study did not measure, or considering the overall energy intake proportion, the protective effect of fat may be a consequence of having higher consumption of carbohydrate.

A dose–response meta-analysis of observational studies suggested that carbohydrate intake had a linear association with MetS risk, with a 2.6% increase in the risk of MetS per 5% energy from carbohydrate intake [48]. In addition, carbohydrate intake from starchy foods with a high glycaemic index (GI > 65) has been shown to contribute more strongly to metabolic disorders and hyperlipidaemia [49]. High consumption of carbohydrates has been consistently associated with a reduced HDL cholesterol level and increased plasma triglyceride levels [50, 51] mainly due to a higher triglyceride content in very low-density lipoprotein (VLDL) particles and overproduction of VLDL particles [52]. In addition to triglyceride and HDL levels, abdominal obesity is also strongly associated with carbohydrate intake [51]. This condition was likely relevant to participants in this study, who were, due to the prevalence of overweight and obesity, already at greater risk of abdominal obesity.

The abdominal obesity component was the most prevalent feature of MetS in this population and another reported MetS population [53]. It is representative of visceral adiposity which is a known risk factor for cardiovascular diseases. Although BMI does not represent adiposity, in the general population, overweight and obese BMI were correlated with increased levels of body fat [54]. Therefore, an individual with overweight-obesity was already at higher risk of abdominal obesity. Furthermore, increased adiposity has been theoretically linked to increased inflammation and metabolism suppression. The biochemical cascade was linked to glucose intolerance and hyperinsulinemia, as well as endothelial dysfunction, which is the predisposing factor for dyslipidaemia and vascular diseases [55, 56].

The present study showed that inadequate exercise had unfavourable effects on MetS risk. Although on the basis of their self-reported data, most participants had sufficient physical activity levels due to their employment as household assistants, when we clustered activity based on intentional physical exercise (playing sports or recreational exercise rather than activity associated with their employment), most participants did not meet recommended levels. Increased sedentary behaviour is associated with an increased risk of high levels of triglycerides, HDL-cholesterol, and fasting glucose [57, 58]. Conversely, around 30 min of moderate-intensity daily exercise improves factors related to MetS [59]. Men who have more than 4 times per week of vigorous, moderate, and strength exercise and more than 6 times per week of walking had a triglyceride level lower than 150 mg/dL [60, 61]. Furthermore, diastolic blood pressure [62] and fasting blood glucose [60] were reported to improve as a result of moderate exercise, particularly aerobic exercise [62].

In observing the development of MetS, we worked on several variables to avoid biases in measurement and analysis. We excluded participants who had limited or incomplete data on blood pressure, fasting blood glucose, HDL, and triglycerides and who were taking antihypertensive, antidiabetic, and cholesterol-lowering medications. We also excluded participants who did not fast prior to blood glucose testing. By doing this, we expected to better understand the incidence of MetS during six years of follow-up with observations every two years. However, we tried to involve as many relevant variables as possible to obtain a more accurate model.

The use of secondary data and limited power were among the limitations of this study. There are some potential sources of bias which lead to inaccuracies in the final results due to the self-reporting of some information, human error in data input, memory limitations, social desirability, intentional misreporting, or may not represent habitual diet, especially in the single 24-hour dietary recall. To manage with the data issue, we used a cleaning procedure to exclude missing information from the MetS criteria, such as instances, when a number was either too small or too excessive, as was the case with blood glucose levels, waist circumference, lipid profiles, and blood pressure, the smaller sample sizes were a result of the stringent data inclusion criteria to minimize follow-up loss and reduce bias. Therefore, the power was potentially affected (considered underpowered) by a smaller sample size, resulting from our rigorous participant selection process, even though the significances between the variables can be clearly produced. Other limitation was the cohort participation relies on the willingness to underwent routine medical checkups, which in population with low health-seeking behaviour such as in most of Indonesian community [63], may lead to bias in participant selection. Although with the large number of participants, and adjustment for potential confounding factors, including dietary intake and physical activity, the risk of selection bias was reduced. Another strength was that the anthropometric and clinical measurements were recorded by trained operators and are more accurate than self-reported measurements. In addition to that, the prospective cohort design employed in this study provided robust and longitudinal insights into the progression of MetS. After weighted adjustment, this study is a sound reflection of the epidemic characteristics of MetS among residents in Bogor District, Indonesia.

Conclusions

Between 2011 and 2018, more than a quarter of the sample developed MetS. Overweight and obesity, insufficient exercise, and a higher quartile of carbohydrate consumption were observed as factors increasing the risk of MetS, even after controlling for several confounding factors. The highest cumulative survival of MetS was reported for participants with underweight BMI and the lowest cumulative survival was reported for participants with obese BMI. Given the importance of these findings, immediate strategic actions are needed to improve the existing early detection and monitoring programmes of NCD that promote community-based healthy lifestyle initiatives and is run by both the government and non-government organisations in Bogor District, Indonesia.

Data availability

The data that support the findings of this study are available from The Ministry of Health, Republic of Indonesia, under the Basic Health Research data, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available with prior officially written permission of the Data Management Laboratory of NIHRD, Ministry of Health, Republic of Indonesia (datin.bkpk@kemkes.go.id).

Abbreviations

BMI:

Body Mass Index

HDL:

High-Density Lipoprotein

MET:

Metabolic Equivalent of Task

MetS:

Metabolic Syndrome

MUFA:

Monounsaturated Fatty Acid

NCEP ATP:

National Cholesterol Education Program’s Adult Treatment Panel

NIHRD:

National Institute of Health Research and Development

NCDs:

Non-Communicable Diseases

PUFA:

Polyunsaturated Fatty Acid

SFA:

Saturated Fatty Acid

SDGs:

Sustainable Development Goals

VLDL:

Very Low-Density Lipoprotein

References

  1. United Nations. Goal 3: Ensure healthy lives and promote well-being for all at all ages. Sustain Dev Goals 2022. https://www.un.org/sustainabledevelopment/health/ (accessed March 2, 2022).

  2. Gowshall M, Taylor-Robinson SD. The increasing prevalence of non-communicable diseases in low-middle income countries: the view from Malawi. Int J Gen Med. 2018;11:255–64. https://doi.org/10.2147/IJGM.S157987.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Bennett JE, Stevens GA, Mathers CD, Bonita R, Rehm J, Kruk ME et al. NCD Countdown. 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet 2018;392:1072–88. https://doi.org/10.1016/S0140-6736(18)31992-5.

  4. WHO. Noncommunicable diseases, Fact. Sheets 2021. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases#:~:text=Noncommunicable diseases (NCDs) kill 41,- and middle-income countries. (accessed March 2, 2022).

  5. Herningtyas EH, Ng TS. Prevalence and distribution of metabolic syndrome and its components among provinces and ethnic groups in Indonesia. BMC Public Health. 2019;19:1–12. https://doi.org/10.1186/s12889-019-6711-7.

    Article  Google Scholar 

  6. Sigit FS, Tahapary DL, Trompet S, Sartono E, Van Willems K, Rosendaal FR, et al. The prevalence of metabolic syndrome and its association with body fat distribution in middle-aged individuals from Indonesia and the Netherlands: a cross-sectional analysis of two population-based studies. Diabetol Metab Syndr. 2020;12:1–11. https://doi.org/10.1186/s13098-019-0503-1.

    Article  CAS  Google Scholar 

  7. Soewondo P, Purnamasari D, Oemardi M, Waspadji S, Soegondo S. Prevalence of Metabolic Syndrome Using NCEP / ATP III Criteria in Jakarta, IndonesiaThe Jakarta Primar1. Dwipayana MP, Suastika K, Saraswati I, Gotera W, Budhiarta A, Sutanegara INDONE et al. Acta Med Indones-Indones J Intern Med. 2010;42:199–203.

  8. Swarup S, Goyal A, Grigorova Y. Metabolic Syndrome. Treasure Isl StatPearls. 2021. https://www.ncbi.nlm.nih.gov/books/NBK459248 (accessed March 2, 2022).

  9. NHLBI. Metabolic Syndrome. NHLBI (National Hear Lung, Blood Institute) n.d. https://www.nhlbi.nih.gov/health-topics/metabolic-syndrome (accessed March 2, 2022).

  10. Agodi A, Maugeri A, Kunzova S, Sochor O, Bauerova H, Kiacova N et al. Association of dietary patterns with metabolic syndrome: results from the kardiovize brno 2030 study. Nutrients 2018;10. https://doi.org/10.3390/nu10070898.

  11. Aekplakorn W, Satheannoppakao W, Putwatana P, Taneepanichskul S, Kessomboon P, Chongsuvivatwong V et al. Dietary pattern and metabolic syndrome in Thai adults. J Nutr Metab 2015;2015. https://doi.org/10.1155/2015/468759.

  12. Hoyas I, Leon-Sanz M. Nutritional challenges in metabolic syndrome. J Clin Med. 2019;8:1–11. https://doi.org/10.3390/jcm8091301.

    Article  CAS  Google Scholar 

  13. Xiao J, Shen C, Chu MJ, Gao YX, Xu GF, Huang JP, et al. Physical activity and sedentary Behavior Associated with components of metabolic syndrome among people in Rural China. PLoS ONE. 2016;11. https://doi.org/10.1371/journal.pone.0147062.

  14. Bankoski A, Harris TB, McClain JJ, Brychta RJ, Caserotti P, Chen KY, et al. Sedentary activity associated with metabolic syndrome independent of physical activity. Diabetes Care. 2011;34:497–503. https://doi.org/10.2337/dc10-0987.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Esmailnasab N, Moradi G, Delaveri A. Risk factors of non-communicable diseases and metabolic syndrome. Iran J Public Health. 2012;41:77–85.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Krishnamoorthy Y, Rajaa S, Murali S, Rehman T, Sahoo J, Kar SS. Prevalence of metabolic syndrome among adult population in India: a systematic review and meta-analysis. PLoS ONE. 2020;15:1–25. https://doi.org/10.1371/journal.pone.0240971.

    Article  CAS  Google Scholar 

  17. Misra A, Bhardwaj S. Obesity and the metabolic syndrome in developing countries: focus on South asians. Nestle Nutr Inst Workshop Ser. 2014;78:133–40. https://doi.org/10.1159/000354952.

    Article  PubMed  Google Scholar 

  18. National Team for the Acceleration of Poverty Reduction. Road Natl Health Insurance (JKN) 2015:108.

  19. Finkelstein EA, Chay J, Bajpai S. The economic burden of self-reported and undiagnosed cardiovascular diseases and diabetes on Indonesian households. PLoS ONE. 2014;9. https://doi.org/10.1371/journal.pone.0099572.

  20. Soewondo P, Ferrario A, Tahapary DL. Challenges in diabetes management in Indonesia: a literature review. Global Health. 2013;9:1–17. https://doi.org/10.1186/1744-8603-9-63.

    Article  Google Scholar 

  21. Patty YFPP, Mufarrihah, Nita Y. Cost of illness of diabetes mellitus in Indonesia: a systematic review. J Basic Clin Physiol Pharmacol. 2021;32:285–95. https://doi.org/10.1515/jbcpp-2020-0502.

    Article  PubMed  Google Scholar 

  22. Agustina R, Dartanto T, Sitompul R, Susiloretni KA, Suparmi, Achadi EL, et al. Universal health coverage in Indonesia: concept, progress, and challenges. Lancet. 2019;393:75–102. https://doi.org/10.1016/S0140-6736(18)31647-7.

    Article  PubMed  Google Scholar 

  23. Nikbakht HA, Rezaianzadeh A, Seif M, Ghaem H. Prevalence of metabolic syndrome and its components among a population-based study in south of Iran, PERSIAN Kharameh cohort study. Clin Epidemiol Glob Heal. 2020;8:678–83. https://doi.org/10.1016/j.cegh.2020.01.001.

    Article  Google Scholar 

  24. Chang CH, Yeh YC, Caffrey JL, Shih SR, Chuang LM, Tu YK. Metabolic syndrome is associated with an increased incidence of subclinical hypothyroidism - A cohort study. Sci Rep. 2017;7:1–8. https://doi.org/10.1038/s41598-017-07004-2.

    Article  CAS  Google Scholar 

  25. Rafati S, Isheh M, Azarbad A, Ghadiri Soufi F, Rahimi A, Kheirandish M. The association of sleep duration and metabolic syndrome in the Bandare-Kong cohort study, a cross-sectional survey (finding from PERSIAN cohort study). Diabetol Metab Syndr. 2021;13:1–9. https://doi.org/10.1186/s13098-021-00737-1.

    Article  CAS  Google Scholar 

  26. Kurniawan F, Manurung MD, Harbuwono DS, Yunir E, Tsonaka R, Pradnjaparamita T, et al. Urbanization and unfavorable changes in metabolic profiles: a prospective cohort study of Indonesian young adults. Nutrients. 2022;14:3326. https://doi.org/10.3390/nu14163326.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Lee MK, Han K, Kim MK, Koh ES, Kim ES, Nam GE, et al. Changes in metabolic syndrome and its components and the risk of type 2 diabetes: a nationwide cohort study. Sci Rep. 2020;10:1–8. https://doi.org/10.1038/s41598-020-59203-z.

    Article  CAS  Google Scholar 

  28. Li Z, Yang X, Yang J, Yang Z, Wang S, Sun F, et al. The cohort study on prediction of incidence of all-cause mortality by metabolic syndrome. PLoS ONE. 2016;11. https://doi.org/10.1371/journal.pone.0154990.

  29. Rustika R, Driyah S, Oemiati R, Hartati NS. Metabolic syndrome predictor: a six-years prospective Chort studies Studi Kohor Prospektif in Bogor, Indonesia. Media Penelit Dan Pengemb Kesehat. 2019;29:215–24. https://doi.org/10.22435/mpk.v29i3.654.

    Article  Google Scholar 

  30. Riyadina W, Sudikno, Pradono J, Rahajeng E, Sirait AM, Oemiati R et al. Laporan akhir penelitian studi kohor faktor risiko penyakit tidak menular 2018. 2018.

  31. Health Development Policy Agency. Non-Communicable Disease Risk Factor Cohort Protocol. Jakarta: 2010.

  32. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735–52. https://doi.org/10.1161/CIRCULATIONAHA.105.169404.

    Article  PubMed  Google Scholar 

  33. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2:231–7. https://doi.org/10.1242/dmm.001180.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Inoue S, Zimmet P, Caterson I, Chunming C, Ikeda Y, Khalid A et al. The Asia– Pacific perspective: redefining obesity and its treatment. 2000.

  35. IPAQ. Guidelines for Data Processing Analysis of the International Physical Activity Questionnaire (IPAQ). Int Phys Act Quest. 2005. https://doi.org/10.1107/S1600536812034848.

    Article  Google Scholar 

  36. World Health Organization. WHO Guidelines on Physical Activity and Sedentary Behaviour. Who 2020:535.

  37. De Silva ST, Niriella MA, Ediriweera DS, Kottahachchi D, Kasturiratne A, De Silva AP, et al. Incidence and risk factors for metabolic syndrome among urban, adult sri lankans: a prospective, 7-year community cohort, follow-up study. Diabetol Metab Syndr. 2019;11:1–7. https://doi.org/10.1186/s13098-019-0461-7.

    Article  CAS  Google Scholar 

  38. Tang X, Liu Q. Prediction of the development of metabolic syndrome by the Markov model based on a longitudinal study in Dalian City. BMC Public Health. 2018;18:1–9. https://doi.org/10.1186/s12889-018-5599-y.

    Article  CAS  Google Scholar 

  39. Gouveia ÉR, Gouveia BR, Marques A, Peralta M, França C, Lima A, et al. Predictors of metabolic syndrome in adults and older adults from amazonas, Brazil. Int J Environ Res Public Health. 2021;18:1–11. https://doi.org/10.3390/ijerph18031303.

    Article  Google Scholar 

  40. Jemal A, Girum T, Kedir S, Bedru A, Mosa H, Assfa K, et al. Metabolic syndrome and its predictors among adults seeking medical care: a trending public health concern. Clin Nutr ESPEN. 2023;54:264–70. https://doi.org/10.1016/j.clnesp.2023.01.034.

    Article  PubMed  Google Scholar 

  41. Gupta R, Jayant SS, Rastogi A, Bhadada SK, Bhansali A, Sachdeva N, et al. Incidence and risk factors for dysglycaemia in Asian-Indians: a 10-year population-based prospective cohort study. Postgrad Med J. 2023;99:176–82. https://doi.org/10.1136/postgradmedj-2021-141243.

    Article  PubMed  Google Scholar 

  42. Kim J, Mun S, Lee S, Jeong K, Baek Y. Prediction of metabolic and pre-metabolic syndromes using machine learning models with anthropometric, lifestyle, and biochemical factors from a middle-aged population in Korea. BMC Public Health. 2022;22:1–10. https://doi.org/10.1186/s12889-022-13131-x.

    Article  Google Scholar 

  43. Kim J, Kim M, Shin Y, Cho JH, Lee D, Kim Y. Association between Dietary Diversity score and metabolic syndrome in Korean adults: A Community-based prospective cohort study. Nutrients. 2022;14. https://doi.org/10.3390/nu14245298.

  44. Sudikno S, Syarief H, Dwiriani CM, Riyadi H, Pradono J. Obesity risk factors among 25–65 years old adults in Bogor City, Indonesia: a prospective cohort study. J Gizi Dan Pangan. 2018;13:55–62. https://doi.org/10.25182/jgp.2018.13.2.55-62.

    Article  Google Scholar 

  45. Julibert A, Bibiloni M, del Tur M. Dietary fat intake and metabolic syndrome in adults: a systematic review. Nutr Metab Cardiovasc Dis. 2019;29:887–905. https://doi.org/10.1016/j.numecd.2019.05.055.

    Article  CAS  PubMed  Google Scholar 

  46. Ayusari AA, Wiboworini B, Damayanti KE, Rahayu D, Widardo W, Lanti Y. Correlation between dietary fat consumption with body mass index and body composition (a preliminary study in community based). Heal Sci J Indones. 2019;10:128–31. https://doi.org/10.22435/hsji.v12i2.2443.

    Article  Google Scholar 

  47. Um YJ, Oh SW, Lee CM, Kwon HT, Joh HK, Kim YJ, et al. Dietary fat intake and the risk of metabolic syndrome in Korean adults. Korean J Fam Med. 2015;36:245–52. https://doi.org/10.4082/kjfm.2015.36.5.245.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Liu Y-S, Wu Q-J, Xia Y, Zhang J-Y, Jiang Y-T, Chang Q, et al. Carbohydrate intake and risk of metabolic syndrome: a dose–response meta-analysis of observational studies. Nutr Metab Cardiovasc Dis. 2019;29:1288–98. https://doi.org/10.1016/j.numecd.2019.09.003.

    Article  CAS  PubMed  Google Scholar 

  49. Feng R, Du S, Chen Y, Zheng S, Zhang W, Na G, et al. High carbohydrate intake from starchy foods is positively associated with metabolic disorders: a Cohort Study from a Chinese population. Sci Rep. 2015;5:1–8. https://doi.org/10.1038/srep16919.

    Article  CAS  Google Scholar 

  50. Ha K, Kim K, Chun OK, Joung H, Song Y. Differential association of dietary carbohydrate intake with metabolic syndrome in the US and Korean adults: data from the 2007–2012 NHANES and KNHANES. Eur J Clin Nutr. 2018;72:848–60. https://doi.org/10.1038/s41430-017-0031-8.

    Article  CAS  PubMed  Google Scholar 

  51. YA CHO, Choi JH. Association between carbohydrate intake and the prevalence of metabolic syndrome in Korean women. Nutrients. 2021;13. https://doi.org/10.3390/nu13093098.

  52. Parks EJ, Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr. 2000;71:412–33. https://doi.org/10.1093/ajcn/71.2.412.

    Article  CAS  PubMed  Google Scholar 

  53. Paley CA, Johnson MI. Abdominal obesity and metabolic syndrome: Exercise as medicine? BMC Sports Sci Med Rehabil. 2018;10:1–8. https://doi.org/10.1186/s13102-018-0097-1.

    Article  Google Scholar 

  54. Shah NR, Braverman ER. Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin. PLoS ONE. 2012;7. https://doi.org/10.1371/journal.pone.0033308.

  55. Temkin AM, Bowers RR, Ulmer CZ, Penta K, Bowden JA, Nyland J, et al. Increased adiposity, inflammation, metabolic disruption and dyslipidemia in adult male offspring of DOSS treated C57BL/6 dams. Sci Rep. 2019;9:1–18. https://doi.org/10.1038/s41598-018-38383-9.

    Article  CAS  Google Scholar 

  56. Canale MP, Di Manca S, Martino G, Rovella V, Noce A, De Lorenzo A et al. Obesity-related metabolic syndrome: Mechanisms of sympathetic overactivity. Int J Endocrinol. 2013;2013. https://doi.org/10.1155/2013/865965.

  57. Crichton GE, Alkerwi A. Physical activity, sedentary behavior time and lipid levels in the Observation of Cardiovascular Risk factors in Luxembourg study. Lipids Health Dis. 2015;14:1–9. https://doi.org/10.1186/s12944-015-0085-3.

    Article  CAS  Google Scholar 

  58. Gennuso KP, Gangnon RE, Thraen-Borowski KM, Colbert LH. Dose–response relationships between sedentary behaviour and the metabolic syndrome and its components. Diabetologia. 2015;58:485–92. https://doi.org/10.1007/s00125-014-3453-z.

    Article  CAS  PubMed  Google Scholar 

  59. Johnson JL, Slentz CA, Houmard JA, Samsa GP, Duscha BD, Aiken LB, et al. Exercise Training Amount and Intensity effects on metabolic syndrome (from studies of a targeted risk reduction intervention through defined Exercise). Am J Cardiol. 2007;100:1759–66. https://doi.org/10.1016/j.amjcard.2007.07.027.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Houmard JA, Tanner CJ, Slentz CA, Duscha BD, McCartney JS, Kraus WE. Effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol. 2004;96:101–6. https://doi.org/10.1152/japplphysiol.00707.2003.

    Article  CAS  PubMed  Google Scholar 

  61. Lee J, Kim Y, Jeon JY. Association between physical activity and the prevalence of metabolic syndrome: from the Korean National Health and Nutrition Examination Survey, 1999–2012. Springerplus 2016;5. https://doi.org/10.1186/s40064-016-3514-5.

  62. Ostman C, Smart NA, Morcos D, Duller A, Ridley W, Jewiss D. The effect of exercise training on clinical outcomes in patients with the metabolic syndrome: a systematic review and meta-analysis. Cardiovasc Diabetol. 2017;16:1–11. https://doi.org/10.1186/s12933-017-0590-y.

    Article  CAS  Google Scholar 

  63. Widayanti AW, Green JA, Heydon S, Norris P. Health-seeking behavior of people in Indonesia: a narrative review. J Epidemiol Glob Health. 2020;10:6. https://doi.org/10.2991/jegh.k.200102.001.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank the National Institute of Health Research and Development, Ministry of Health, Republic of Indonesia that provided the access to the data for this study and the Directorate of Research and Community Engagement of Universitas Indonesia as the funder. The funder was not involved in the manuscript’s study, drafting, evaluation, or approval. We also convey our gratitude to Doni Hikmat Ramdhan for his thorough review and feedback to authors.

Funding

This work was supported by the Directorate of Research and Community Engagement of Universitas Indonesia, grant number NKB-625/UN2.RST/HKP.05.00/2022.

Author information

Authors and Affiliations

  1. Department of Public Health Nutrition, Faculty of Public Health, Universitas Indonesia, 16424, Depok, West Java, Indonesia

    Nurul Dina Rahmawati, Fadila Wirawan & Latifah Farsia

  2. Department of Health Policy and Administration, Faculty of Public Health, Universitas Indonesia, 16424, Depok, West Java, Indonesia

    Helen Andriani

  3. Institute of Public Health, School of Medicine, National Yang-Ming Chiao Tung University, Taipei, 112, Taiwan

    Alexander Waits

  4. Department of Biostatistics, Faculty of Public Health, Universitas Indonesia, 16424, Depok, West Java, Indonesia

    Khobir Abdul Karim Taufiqurahman

Authors
  1. Nurul Dina Rahmawati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helen Andriani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fadila Wirawan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Latifah Farsia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alexander Waits
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Khobir Abdul Karim Taufiqurahman
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

NDR had primary responsibility for writing of the article. FW and KAKT carried out data analyses. NDR, HA, FW and LF conceived the idea and initiated the analysis plan for the current study. HA and AW supervised the current study. FW and LF reviewed and commented on the draft. All authors coordinated the study and provided comments on drafts of the manuscript and have revised and approved the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Helen Andriani.

Ethics declarations

Ethics approval and consent to participate

Ethical approval was waived as we used secondary data. As for the primary data of the Special Study of Non-Communicable Disease, Komisi Etik Penelitian Kesehatan, Badan Penelitian dan Pengembangan Kesehatan (Ethical Committee of Health Research, National Institute of Health Research and Development (NIHRD), Ministry of Health, Republic of Indonesia) had given their approval with the reference number LB.02.01/2/KE.076/2018. All methods were carried out in accordance with relevant guidelines and regulations (Declaration of Helsinki). Additional ethical review board approval was obtained from the Komisi Etik Riset dan Pengabdian Kesehatan Masyarakat Fakultas Kesehatan Masyarakat Universitas Indonesia (The Research and Community Engagement Ethical Committee, Faculty of Public Health Universitas Indonesia) with reference number 534/UN2.F10.D11/PPM.00.02/2022. All participants aged 15 years and above, or a parent and/or legal guardian (in the case of children under 16) had given their written informed consent prior to participating in the 2011–2018 Non-Communicable Disease Cohort Study. Participants’ willingness to participate and written informed consent was reassessed before on-site laboratory testing and blood sample collection.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

. The 6-year Survival of MetS based on the Risk Factors

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rahmawati, N.D., Andriani, H., Wirawan, F. et al. Body mass index as a dominant risk factor for metabolic syndrome among indonesian adults: a 6-year prospective cohort study of non-communicable diseases. BMC Nutr 10, 43 (2024). https://doi.org/10.1186/s40795-024-00856-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40795-024-00856-8

Keywords

BMC Nutrition

ISSN: 2055-0928

Contact us